Management of Elevated Serum Creatinine

Initial Assessment and Classification

• The American Journal of Kidney Diseases recommends reviewing previous creatinine values from the last 3 months to establish if elevation is acute or chronic 3, 1
• AKI is defined by an increase in serum creatinine by ≥0.3 mg/dL within 48 hours, OR increase to ≥1.5 times baseline within 7 days, OR urine output <0.5 mL/kg/h for 6 hours 3
• Calculate the rate of change to assess progression velocity 1

Immediate Management Steps

• The American College of Cardiology and other societies recommend immediately discontinuing nephrotoxic medications: NSAIDs, aminoglycosides, vancomycin, amphotericin B, certain chemotherapy agents 1, 2, 4
• Hold ACE inhibitors/ARBs temporarily if AKI is present with volume depletion, but do not discontinue for minor increases ≤30% from baseline in stable patients 1, 2
• Stop diuretics temporarily if hypovolemia is suspected 3, 2

Laboratory Evaluation

• The National Kidney Foundation recommends a complete metabolic panel: electrolytes, BUN, creatinine, calcium, phosphate 1
• Complete blood count to assess for anemia (common in CKD) 1, 4
• Urinalysis with microscopy: look for casts, cells, crystals, protein 1
• Urine albumin-to-creatinine ratio (UACR) to quantify proteinuria 1, 4

Stage-Based Management

• For Stage 1 AKI, discontinue nephrotoxic agents immediately and ensure adequate volume status and perfusion pressure 5, 2
• For Stage 2 AKI, consider vasoconstrictor therapy + albumin if hepatorenal syndrome suspected 3
• For Stage 3 AKI, consider ICU admission for close monitoring and initiate renal replacement therapy (RRT) if necessary 5, 3

Specific Clinical Scenarios

• In heart failure with elevated creatinine, therapy with ACE inhibitor or ARB typically causes mild, transient creatinine elevation - this is acceptable 7
• In diabetes with elevated creatinine, optimize blood pressure control to <140/90 mmHg to reduce CKD progression 1, 2
• In cirrhosis with AKI, perform diagnostic paracentesis to evaluate for spontaneous bacterial peritonitis 3, 2

Indications for Nephrology Referral

• Refer immediately if eGFR <30 mL/min/1.73m², rapid progression, persistent significant proteinuria, or difficult-to-manage complications 1, 4, 5

Monitoring Protocol

• In acute settings, monitor daily creatinine and electrolytes until stabilized, and weekly creatinine monitoring during acute management phase 2
• In chronic settings, monitor both albuminuria and eGFR annually minimum, and more frequently if eGFR <60 mL/min/1.73m² or progressive disease 2, 4